Clinical Trial Update: Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the potential for oral pentoxifylline to improve hemoglobin in patients with anemia of chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: Anemia of Chronic Kidney Disease | Phase 2 | Status: COMPLETED